186 related articles for article (PubMed ID: 28471257)
1. Ras-ling with new therapeutic targets for metastasis.
Mason JA; Schafer ZT
Small GTPases; 2019 Jul; 10(4):249-253. PubMed ID: 28471257
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells.
Mason JA; Davison-Versagli CA; Leliaert AK; Pape DJ; McCallister C; Zuo J; Durbin SM; Buchheit CL; Zhang S; Schafer ZT
Cell Death Differ; 2016 Aug; 23(8):1271-82. PubMed ID: 26915296
[TBL] [Abstract][Full Text] [Related]
3. SGK-1 and PHLPP1: Ras-mediated effectors during ECM-detachment.
Mason JA; Schafer ZT
Cell Cycle; 2016 Sep; 15(17):2233-4. PubMed ID: 27267605
[No Abstract] [Full Text] [Related]
4. SGK1 signaling promotes glucose metabolism and survival in extracellular matrix detached cells.
Mason JA; Cockfield JA; Pape DJ; Meissner H; Sokolowski MT; White TC; Valentín López JC; Liu J; Liu X; Martínez-Reyes I; Chandel NS; Locasale JW; Schafer ZT
Cell Rep; 2021 Mar; 34(11):108821. PubMed ID: 33730592
[TBL] [Abstract][Full Text] [Related]
5. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
Dhawan NS; Scopton AP; Dar AC
Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
[TBL] [Abstract][Full Text] [Related]
6. Targeting the RAS-dependent chemoresistance: The Warburg connection.
Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
[TBL] [Abstract][Full Text] [Related]
8. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.
Khwaja A; Rodriguez-Viciana P; Wennström S; Warne PH; Downward J
EMBO J; 1997 May; 16(10):2783-93. PubMed ID: 9184223
[TBL] [Abstract][Full Text] [Related]
9. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
10. Biology, pathology, and therapeutic targeting of RAS.
Rhett JM; Khan I; O'Bryan JP
Adv Cancer Res; 2020; 148():69-146. PubMed ID: 32723567
[TBL] [Abstract][Full Text] [Related]
11. The regulation of cancer cell death and metabolism by extracellular matrix attachment.
Buchheit CL; Rayavarapu RR; Schafer ZT
Semin Cell Dev Biol; 2012 Jun; 23(4):402-11. PubMed ID: 22579674
[TBL] [Abstract][Full Text] [Related]
12. Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?
Mason JA; Hagel KR; Hawk MA; Schafer ZT
Trends Cancer; 2017 Jul; 3(7):475-481. PubMed ID: 28718402
[TBL] [Abstract][Full Text] [Related]
13. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
Sacco E; Spinelli M; Vanoni M
Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
Aguilar BJ; Zhou H; Lu Q
Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
[TBL] [Abstract][Full Text] [Related]
16. Ras/Raf signalling and emerging pharmacotherapeutic targets.
Kolch W
Expert Opin Pharmacother; 2002 Jun; 3(6):709-18. PubMed ID: 12036410
[TBL] [Abstract][Full Text] [Related]
17. Challenges in Ras therapeutics in pancreatic cancer.
Choi M; Bien H; Mofunanya A; Powers S
Semin Cancer Biol; 2019 Feb; 54():101-108. PubMed ID: 29170065
[TBL] [Abstract][Full Text] [Related]
18. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
19. Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells.
Teraishi F; Guo W; Zhang L; Dong F; Davis JJ; Sasazuki T; Shirasawa S; Liu J; Fang B
Cancer Res; 2006 Jun; 66(12):6072-9. PubMed ID: 16778179
[TBL] [Abstract][Full Text] [Related]
20. Targeting oncogenic Ras signaling in hematologic malignancies.
Ward AF; Braun BS; Shannon KM
Blood; 2012 Oct; 120(17):3397-406. PubMed ID: 22898602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
